Loading...
•
Jun 30, 2024
Establishment Labs Q2 2024 Earnings Report
Reported strong sequential revenue growth and improved adjusted EBITDA.
Key Takeaways
Establishment Labs reported a decrease in revenue for the second quarter of 2024, with $44.1 million compared to $48.6 million in the same period of 2023. However, the company saw an improvement in gross profit margin and a reduction in operating expenses, leading to a smaller loss from operations and an improved adjusted EBITDA loss. The company is awaiting FDA approval of Motiva Implants.
Second quarter worldwide revenue was $44.1 million.
Gross profit for the second quarter was $28.9 million, or 65.6% of revenue.
Second quarter loss from operations was $9.3 million.
Cash balance of $54.6 million as of June 30, 2024.
Forward Guidance
The company's 2024 revenue guidance remains $174 million to $184 million, an increase of 5% to 11% over 2023.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...